Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+12.05%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$20.1B
AUM Growth
+$3.51B
(+21%)
Cap. Flow
+$2.14B
Cap. Flow
% of AUM
10.66%
Top 10 Holdings %
Top 10 Hldgs %
20.21%
Holding
1,578
New
129
Increased
965
Reduced
349
Closed
104
Top Buys
| 1 |
Amazon
AMZN
|
$95.3M |
| 2 |
Apple
AAPL
|
$76.5M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$67.7M |
| 4 |
Microsoft
MSFT
|
$64M |
| 5 |
HEAL
Global X Funds Global X HealthTech ETF
HEAL
|
$58.8M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$107M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$75.4M |
| 3 |
Dynatrace
DT
|
$49.5M |
| 4 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$47.1M |
| 5 |
Tesla
TSLA
|
$45.9M |
Sector Composition
| 1 | Technology | 26.07% |
| 2 | Consumer Discretionary | 11.05% |
| 3 | Healthcare | 8.15% |
| 4 | Communication Services | 7.46% |
| 5 | Energy | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Ambarella
AMBA
$3.54B
| $3.91M | 0.02% |
74,884
+19,472
| +35% | +$1.02M |
|
602
Ascendis Pharma
ASND
$12.5B
| $3.88M | 0.02% |
25,135
+4,973
| +25% | +$767K |
|
|
BLUE
603
DELISTED
bluebird bio
BLUE
| $3.88M | 0.02% |
5,506
+1,686
| +44% | +$1.19M |
|
604
Northern Trust
NTRS
$24.3B
| $3.85M | 0.02% |
49,328
+8,706
| +21% | +$679K |
|
605
Neurocrine Biosciences
NBIX
$14.3B
| $3.83M | 0.02% |
39,629
+1,186
| +3% | +$115K |
|
606
Ventas
VTR
$30.9B
| $3.82M | 0.02% |
91,094
+25,664
| +39% | +$1.08M |
|
|
MDRX
607
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.82M | 0.02% |
+469,140
| New | +$3.82M |
|
608
Elanco Animal Health
ELAN
$9.16B
| $3.8M | 0.02% |
137,852
+32,121
| +30% | +$884K |
|
609
SBA Communications
SBAC
$21.2B
| $3.79M | 0.02% |
11,907
+271
| +2% | +$86.3K |
|
610
Cummins
CMI
$55.1B
| $3.79M | 0.02% |
17,953
+136
| +0.8% | +$28.7K |
|
611
Travelers Companies
TRV
$62B
| $3.79M | 0.02% |
34,976
+4,254
| +14% | +$461K |
|
612
HUTCHMED
HCM
$2.74B
| $3.78M | 0.02% |
116,990
-52,341
| -31% | -$1.69M |
|
613
AvalonBay Communities
AVB
$27.8B
| $3.71M | 0.02% |
24,852
+3,388
| +16% | +$506K |
|
614
Ultragenyx Pharmaceutical
RARE
$3.07B
| $3.64M | 0.02% |
44,336
+12,691
| +40% | +$1.04M |
|
|
LAC
615
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $3.64M | 0.02% |
321,207
+34,102
| +12% | +$387K |
|
616
Lincoln Electric
LECO
$13.5B
| $3.63M | 0.02% |
39,422
+8,006
| +25% | +$737K |
|
617
Peloton Interactive
PTON
$3.27B
| $3.62M | 0.02% |
36,506
-10,191
| -22% | -$1.01M |
|
618
EOG Resources
EOG
$64.4B
| $3.61M | 0.02% |
100,431
+19,227
| +24% | +$691K |
|
619
Global X Genomics & Biotechnology ETF
GNOM
$191M
| $3.6M | 0.02% |
+50,083
| New | +$3.6M |
|
620
NetApp
NTAP
$23.7B
| $3.59M | 0.02% |
81,794
-30,860
| -27% | -$1.35M |
|
621
Bio-Rad Laboratories Class A
BIO
$8B
| $3.57M | 0.02% |
6,934
+1,858
| +37% | +$956K |
|
622
KeyCorp
KEY
$20.8B
| $3.53M | 0.02% |
296,148
+49,800
| +20% | +$594K |
|
623
Allstate
ALL
$53.1B
| $3.51M | 0.02% |
37,303
+7,012
| +23% | +$660K |
|
624
ON Semiconductor
ON
$20.1B
| $3.47M | 0.02% |
159,843
+27,018
| +20% | +$586K |
|
625
Williams-Sonoma
WSM
$24.7B
| $3.45M | 0.02% |
76,244
+47,804
| +168% | +$2.16M |
|